Internal Medicine, Rheumatology · Asheville, NC
NPI
1457513590
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4 Vanderbilt Park Dr Ste 200
Asheville, NC, 28803
Phone (828) 258-9533
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
194,639 services
Medicare patients, 2024
408
Average age 74
Drug cost, 2024
$1.6M
1,721 prescriptions
Company payments, 2025
$884
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adrian Vazquez was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 78,000 times for 31 patients. In total Adrian Vazquez billed 194,639 services in 88 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 78,000 | 31 | $3.60 | $280K |
| J3262 Injection, tocilizumab, 1 mg | Office | 31,280 | 19 | $4.69 | $147K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 31,200 | 52 | $9.08 | $283K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 20,575 | 52 | $33.31 | $685K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 12,600 | 27 | $8.43 | $106K |
| J0897 Injection, denosumab, 1 mg | Office | 5,280 | 71 | $20.31 | $107K |
| 96372 Injection Administration | Office | 610 | 126 | $11.06 | $6,745 |
| 99214 Office E&M - Established | Office | 578 | 254 | $87.05 | $50K |
| 82565 Clinical Chemistry | Office | 544 | 246 | $4.99 | $2,716 |
| 85025 Blood Count | Office | 503 | 221 | $7.56 | $3,805 |
| 80076 Clinical Chemistry | Office | 494 | 214 | $7.96 | $3,933 |
| 85652 Clinical Chemistry | Office | 484 | 213 | $2.64 | $1,277 |
| 86140 Clinical Chemistry | Office | 483 | 216 | $5.05 | $2,438 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 480 | 222 | $11.67 | $5,603 |
| 96413 Chemotherapy Administration | Office | 400 | 94 | $97.36 | $39K |
By year: 2022 $1.9M for 139,291 services; 2023 $1.9M for 163,850 services; 2024 $2.1M for 194,639 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82565 Clinical Chemistry | 544 | 246 | $4.99 | $2,716 |
| 85025 Blood Count | 503 | 221 | $7.56 | $3,805 |
| 80076 Clinical Chemistry | 494 | 214 | $7.96 | $3,933 |
| 85652 Clinical Chemistry | 484 | 213 | $2.64 | $1,277 |
| 86140 Clinical Chemistry | 483 | 216 | $5.05 | $2,438 |
| 36415 Venipuncture Blood Collection | 355 | 169 | $8.65 | $3,071 |
| 82310 Clinical Chemistry | 99 | 62 | $5.06 | $501 |
| 86481 Immunoassay | 91 | 89 | $98.00 | $8,918 |
| 82306 Clinical Chemistry | 78 | 76 | $29.01 | $2,263 |
| 86160 Immunoassay | 60 | 15 | $11.37 | $682 |
Medicare prescription drug claims, 2024
In 2024, the drug Adrian Vazquez prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 447 prescriptions and refills. In total Adrian Vazquez wrote 1,721 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 447 | 1,187 | 120 | $14K |
| Methotrexate Methotrexate Sodium | 245 | 532 | 61 | $5,059 |
| Prednisone Generic | 240 | 387 | 74 | $1,295 |
| Allopurinol Generic | 93 | 240 | 27 | $808 |
| Enbrel Sureclick Etanercept | 80 | 85 | Under 11 | $650K |
| Alendronate Sodium Generic | 67 | 161 | 22 | $517 |
| Colchicine Generic | 59 | 131 | 21 | $2,515 |
| Duloxetine Hcl Generic | 42 | 107 | 11 | $364 |
| Sulfasalazine Generic | 41 | 93 | Under 11 | $1,199 |
| Celecoxib Generic | 30 | 52 | Under 11 | $340 |
| Leflunomide Generic | 27 | 57 | Under 11 | $1,670 |
| Febuxostat Generic | 25 | 51 | Under 11 | $1,742 |
| Folic Acid Generic | 21 | 61 | Under 11 | $186 |
| Methylprednisolone Generic | 19 | 20 | Under 11 | $394 |
| Enbrel Etanercept | 18 | 18 | Under 11 | $134K |
Brand drugs: 311 claims; generic drugs: 1,395 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adrian Vazquez $884 ($884 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $598.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.